Endometriosis is one of the most widespread chronic conditions affecting approximately 5–10% of women in their reproductive years, translating to around 176 million women worldwide. The estimated range of the prevalence of endometriosis is up to 50% in infertile women.

It is a benign disease causing the following most commonly occurred symptoms: dysmenorrhea, dyspareunia, heavy bleeding, pelvic pain, dysuria, dyschesia and it is often associated with sub-fertility or infertility. The daily activities and the sexual life are negatively affected because of the painful and long-lasting symptoms, and as such it has a significant impact on various aspects of women’s lives. According to the American Society for Reproductive Medicine (ASRM), Endometriosis should be viewed as a chronic disease that requires a life-long management plan with the goal of maximizing the use of medical treatment and avoiding repeated surgical procedures.

In daily practice the surgical intervention and medical therapies are used in the management of endometriosis aiming for the relief of the pain and other symptoms, the reduction of endometriotic lesions and improvement the quality of life.